Cobb C E, Beth A H, Corbin J D
Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee 37232.
J Biol Chem. 1987 Dec 5;262(34):16566-74.
By a new procedure, the holoenzyme of bovine heart type II cAMP-dependent protein kinase was purified to homogeneity as determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). A high performance liquid chromatography-DEAE purification step resolved two distinct peaks of protein kinase activity, which were designated Peak 1 and Peak 2 based on their order of elution. The two peaks exhibited similar Stokes radii and sedimentation coefficients. They had similar ratios of regulatory to catalytic subunits both by densitometric scanning of SDS-PAGE bands and by the ratios of equilibrium [3H]cAMP binding to maximal kinase activity. These results suggested that the holoenzyme of each peak contained two regulatory subunits and two catalytic subunits, although a subpopulation of holoenzyme lacking one catalytic subunit also appeared to be present in Peak 2. Assays of cAMP indicated that the Peak 1 holoenzyme was cAMP-free, but half of the Peak 2 holoenzyme cAMP binding sites contained cAMP. Determination of [3H]cAMP dissociation rates showed that the cAMP was equally distributed in binding Site 1 and Site 2 of Peak 2. Although SDS-PAGE analysis ruled out conversions by proteolysis or autophosphorylation-dephosphorylation, Peak 1 could be partially converted to Peak 2 by the addition of subsaturating amounts of cAMP. Interconvertibility of the two holoenzyme peaks strongly suggested that the difference between the two peaks was caused by the presence of cAMP in Peak 2. Peak 2 holoenzyme, as compared to Peak 1, had enhanced binding in nonequilibrium [3H]cIMP and [3H]cAMP binding assays, as was expected due to the presence of cAMP and to the known positive cooperativity in binding of cyclic nucleotides to the kinase. The positive cooperativity in kinase activation, as indicated by the Hill coefficient, was greater for Peak 2 than Peak 1, but the cAMP concentration required for half-maximal activation (Ka) of each of the two peaks was very similar. In conclusion, Peak 2 is an inactive ternary complex of cAMP, regulatory subunit, and catalytic subunit, and Peak 1 is a cAMP-free holoenzyme. The cAMP-bound form may represent a major cellular form of the enzyme which is primed for activation.
通过一种新方法,牛心II型cAMP依赖性蛋白激酶的全酶被纯化至同质,这是通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)确定的。高效液相色谱-DEAE纯化步骤分离出两个不同的蛋白激酶活性峰,根据洗脱顺序将它们命名为峰1和峰2。这两个峰表现出相似的斯托克斯半径和沉降系数。通过SDS-PAGE条带的光密度扫描以及平衡[3H]cAMP结合与最大激酶活性的比率,它们具有相似的调节亚基与催化亚基比率。这些结果表明,每个峰的全酶包含两个调节亚基和两个催化亚基,尽管在峰2中似乎也存在缺乏一个催化亚基的全酶亚群。cAMP分析表明,峰1全酶不含cAMP,但峰2全酶一半的cAMP结合位点含有cAMP。[3H]cAMP解离速率的测定表明,cAMP在峰2的结合位点1和位点2中均匀分布。尽管SDS-PAGE分析排除了蛋白水解或自磷酸化-去磷酸化导致的转化,但通过添加亚饱和量的cAMP,峰1可以部分转化为峰2。两个全酶峰的相互转化强烈表明,两个峰之间的差异是由峰2中cAMP的存在引起的。与峰1相比,峰2全酶在非平衡[3H]cIMP和[3H]cAMP结合测定中具有增强的结合,这是由于cAMP的存在以及环状核苷酸与激酶结合中已知的正协同作用所预期的。如希尔系数所示,峰2在激酶激活中的正协同作用比峰1更大,但两个峰各自达到半最大激活所需的cAMP浓度(Ka)非常相似。总之,峰2是cAMP、调节亚基和催化亚基的无活性三元复合物,峰1是不含cAMP的全酶。结合cAMP的形式可能代表该酶的主要细胞形式,其已准备好被激活。